Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A 12 Week, Open-Label, Safety Trial Of Pregabalin In Patients With Fibromyalgia

NCT00346034 is registered in ClinicalTrials.gov with Pfizer's Upjohn has merged with Mylan to form Viatris Inc. as lead sponsor.

NCT NCT00346034
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00346034 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A 12 Week, Open-Label, Safety Trial Of Pregabalin In Patients With Fibromyalgia
Lead sponsor
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Phase
Phase 3
Overall status
Completed
Start date
December 31, 2006
Completion date
February 29, 2008
Enrollment
357 (actual)
Sites
51

Conditions

As the registry lists them; a condition with its own page is linked.

fibromyalgia